Northwire Canada EditionTuesday, July 14, 2026
Sign inSubscribe
Northwire
⌕
WDO 26.04 −0.9% FVI 11.84 −1.6% OM 1.75 −1.7% ETG 2.99 +0.0% ARTG 31.47 −4.6% LUC 0.163 +1.6% AFM 1.38 +0.0% IMG 20.95 −3.5% CPAU 0.150 +3.5% MMX 0.075 +7.1% IE 12.47 −2.4% SASK 1.09 −1.8% MOG 0.390 +2.6% XIM 0.070 −6.7% S 0.110 −29.0% OMI 0.300 −4.8% WDO 26.04 −0.9% FVI 11.84 −1.6% OM 1.75 −1.7% ETG 2.99 +0.0% ARTG 31.47 −4.6% LUC 0.163 +1.6% AFM 1.38 +0.0% IMG 20.95 −3.5% CPAU 0.150 +3.5% MMX 0.075 +7.1% IE 12.47 −2.4% SASK 1.09 −1.8% MOG 0.390 +2.6% XIM 0.070 −6.7% S 0.110 −29.0% OMI 0.300 −4.8%

Healthcare

Page 51
  1. Mar 09, 2026 · 14:53 · DTC

    Defence Therapeutics closes $9.59M private placement

    Defence Therapeutics closes $9.59M private placement

    01
  2. Mar 09, 2026 · 08:30 · PRN

    Profound Medical to Host Investor Call to Discuss First Clinical Outcomes from the CAPTAIN Trial on March 13; Participate in ROTH Investor Conference on March 22-24

    Profound Medical to Host Investor Call to Discuss First Clinical Outcomes from the CAPTAIN Trial on March 13; Participate in ROTH Investor Conference on March 22-24

    02
  3. Mar 09, 2026 · 08:00 · VST

    Hydreight Announces Normal Course Issuer Bid

    Hydreight Announces Normal Course Issuer Bid

    03
  4. Mar 09, 2026 · 08:00 · NURS

    Hydreight Announces Normal Course Issuer Bid

    Hydreight Announces Normal Course Issuer Bid

    04
  5. Mar 09, 2026 · 07:30 · VHI

    VitalHub Announces Novari Health AI-Enhanced Referral Management Deployment

    VitalHub Announces Novari Health AI-Enhanced Referral Management Deployment

    05
  6. Mar 09, 2026 · 07:01 · TELO

    Telo Genomics Closes Second and Final Tranche of Convertible Debentures Financing

    Telo Genomics Closes Second and Final Tranche of Convertible Debentures Financing

    06
  7. Mar 09, 2026 · 07:01 · TLT

    Theralase(R) Demonstrates That X-Ray-Activated Rutherrin(R) Is Significantly More Effective than Radiation Alone in the Destruction of Muscle Invasive Bladder Cancer

    Theralase(R) Demonstrates That X-Ray-Activated Rutherrin(R) Is Significantly More Effective than Radiation Alone in the Destruction of Muscle Invasive Bladder Cancer

    07
  8. Mar 06, 2026 · 19:30 · NVRS

    Noveris Announces Conversion Of Debentures; Filing Of Early Warning Reports By JJK Holdings Ltd. And Joshua Bartch

    Noveris Announces Conversion Of Debentures; Filing Of Early Warning Reports By JJK Holdings Ltd. And Joshua Bartch

    08
  9. Mar 06, 2026 · 18:24 · WELL

    Well Health to release 2025 results March 19

    Well Health to release 2025 results March 19

    09
  10. Mar 06, 2026 · 17:20 · CYTO

    Cytophage Announces Formation of Special Committee of Independent Directors to Evaluate Strategic Alternatives

    Cytophage Announces Formation of Special Committee of Independent Directors to Evaluate Strategic Alternatives

    10
  11. Mar 06, 2026 · 16:24 · NVRS

    Noveris converts $8.18-million in debentures

    Noveris converts $8.18-million in debentures

    11
  12. Mar 06, 2026 · 10:13 · WELL

    WELL Health to Report Fourth Quarter and Year End 2025 Financial Results on March 19, 2026

    WELL Health to Report Fourth Quarter and Year End 2025 Financial Results on March 19, 2026

    12
  13. Mar 06, 2026 · 09:09 · AFV

    Apolo V Acquisition Corp. Announces Shareholder Approvals

    Apolo V Acquisition Corp. Announces Shareholder Approvals

    13
  14. Mar 05, 2026 · 21:01 · QIPT

    Quipt acquisition by Kingswood, Forager okayed by court

    Quipt acquisition by Kingswood, Forager okayed by court

    14
← Newer Older →